Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion

IntroductionOur previous studies detected focal disruptions in myoepithelial cell layers of several ducts with carcinoma in situ. The cell cluster overlying each of the myoepithelial disruptions showed a marked reduction in or a total loss of immunoreactivity for the estrogen receptor (ER). This is in contrast to the adjacent cells within the same duct, which were strongly immunoreactive for the ER. The current study attempts to confirm and expand previous observations on a larger scale.MethodsParaffin sections from 220 patients with ER-positive intraductal breast tumors were double immunostained with the same protocol previously used. Cross-sections of ducts lined by ≥ 40 epithelial cells were examined for myoepithelial cell layer disruptions and for ER expression. In five selected cases, ER-negative cells overlying the disrupted myoepithelial cell layer and adjacent ER-positive cells within the same duct were separately microdissected and assessed for loss of heterozygosity and microsatellite instability.ResultsOf the 220 cases with 5698 duct cross-sections examined, 94 showed disrupted myoepithelial cell layers with 405 focal disruptions. Of the 94 cases, 79 (84%) contained only ER-negative cell clusters, nine (9.6%) contained both ER-negative and ER-positive cell clusters, and six (6.4%) contained only ER-positive cell clusters overlying disrupted myoepithelial cell layers. Of the 405 disruptions, 350 (86.4%) were overlain by ER-negative cell clusters and 55 (13.6%) were overlain by ER-positive cell clusters (P < 0.01). Microdissected ER-negative and ER-positive cells within the same duct from all five selected cases displayed a different frequency or pattern of loss of heterozygosity and/or microsatellite instability at 10 of the 15 DNA markers.ConclusionsCells overlying focally disrupted myoepithelial layers and their adjacent counterparts within the same duct displayed different immunohistochemical and molecular features. These features potentially represent an early sign of the formation of a biologically more aggressive cell clone and the myoepithelial cell layer breakdown possibly associated with tumor progression or invasion.

[1]  M. Sheikh,et al.  Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? , 1994, Invasion & metastasis.

[2]  Y. Man,et al.  Morphofunctional Features of Intraductal Hyperplasia, Atypical Intraductal Hyperplasia, and Various Grades of Intraductal Carcinoma , 1995 .

[3]  L. Hayman,et al.  Correspondence , 1992, Neuroradiology.

[4]  N. Shikata,et al.  Immunohistochemical localization of myoepithelial cells and basement membrane in normal, benign and malignant human breast lesions , 2004, Virchows Archiv A.

[5]  M. Dowsett,et al.  Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  Mina J Bissell,et al.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.

[7]  A. Sapino,et al.  Oxytocin enhances myoepithelial cell differentiation and proliferation in the mouse mammary gland. , 1993, Endocrinology.

[8]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[9]  L. Liotta,et al.  Proteolytic Enzymes in Cancer Invasion and Metastasis , 1986, Seminars in thrombosis and hemostasis.

[10]  H. Gardner,et al.  Mammary gland development, reproductive history, and breast cancer risk. , 1999, Cancer research.

[11]  O. Petersen,et al.  Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. , 1987, Cancer research.

[12]  C. Bodian,et al.  Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations. , 1999, The American journal of surgical pathology.

[13]  L. Gaboury,et al.  Multifocal, Nascent, and Invasive Myoepithelial Carcinoma (Malignant Myoepithelioma) of the Breast: An Immunohistochemical and Ultrastructural Study , 2002, International journal of surgical pathology.

[14]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.

[15]  J. Russo,et al.  Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland , 1999, Breast Cancer Research and Treatment.

[16]  G. Panayi,et al.  Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. , 2001, Rheumatic diseases clinics of North America.

[17]  Illinois.,et al.  Cancer Genetics , 1976, British Journal of Cancer.

[18]  Z. Shao,et al.  The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. , 1998, Experimental cell research.

[19]  G. Bratthauer,et al.  Allelic Losses at 3p and 11p Are Detected in Both Epithelial and Stromal Components of Cervical Small-Cell Neuroendocrine Carcinoma , 2001, Applied immunohistochemistry & molecular morphology : AIMM.

[20]  G. Bratthauer,et al.  Multiple use of slab gels in sequencing apparatus for separation of polymerase chain reaction products , 2001, Electrophoresis.

[21]  R. Schiff,et al.  Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. , 2003, Cancer research.

[22]  J. Tobacman.  Filament Disassembly and Loss of Mammary Myoepithelial Cells after Exposure to λ-Carrageenan , 1997 .

[23]  M. Bissell,et al.  The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion , 2001, Breast Cancer Research.

[24]  R Clarke,et al.  Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Moll,et al.  Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas , 1998, Virchows Archiv.

[26]  L. Hennighausen,et al.  Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. , 1995, Development.

[27]  S. Barsky,et al.  The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.

[28]  G. Bratthauer,et al.  An improved method for DNA extraction from paraffin sections. , 2001, Pathology, research and practice.

[29]  Murphy Lc.  Mechanisms of hormone independence in human breast cancer. , 1998 .

[30]  N. Miosge,et al.  The ultrastructural composition of basement membranes in vivo. , 2001, Histology and histopathology.

[31]  J. Tobacman.  Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan. , 1997, Cancer research.

[32]  S. Barsky,et al.  Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[33]  J. Tobacman,et al.  Steroid sulfatase activity and expression in mammary myoepithelial cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[35]  A. Hand,et al.  Persistence of a perinatal cellular phenotype in submandibular glands of adult rat. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  R. Coombes,et al.  The human mammary gland basement membrane is integral to the polarity of luminal epithelial cells. , 1999, Experimental cell research.

[37]  F. Schmitt,et al.  Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis. , 1995, European journal of cancer.

[38]  G. Bratthauer,et al.  Five useful approaches for generating more valid gel images of loss of heterozygosity and clonality analysis with an automated 377 DNA sequencer. , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[39]  K. Campbell,et al.  A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. , 2002, Cancer research.

[40]  J. Pasqualini.  Breast cancer: Prognosis, Treatment and Prevention Published in July 2002 by Marcel Dekker Inc., New York, USA; Basel, Switzerland; 656 pages; ISBN: 0-8247-0712-5; US$ 165.00 , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.

[42]  G. Bratthauer,et al.  A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers , 2003, Breast Cancer Research.

[43]  I. Zusman,et al.  The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study. , 2002, Anticancer research.

[44]  I. Gannot,et al.  Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma , 2002, British Journal of Cancer.